InvestorsHub Logo
Followers 618
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: sox040713 post# 155650

Sunday, 07/24/2016 8:55:12 PM

Sunday, July 24, 2016 8:55:12 PM

Post# of 402589
Thanks... I was looking for just one location giving the info, but, this will do fine. ;)







In Reply to 'sox040713'
The proof can be found in this PR.

"the data from its Phase 1 trial of the Company’s anti-psoriasis drug candidate Prurisol™ for the conversion of Prurisol to abacavir indicated “the areas are within passing Bioequivalency limits.” Cellceutix believes it has met the primary endpoints and objectives of the study."

http://cellceutix.com/cellceutix-anti-psoriasis-drug-prurisol-meets-primary-endpoint-of-clinical-trial/#sthash.ccq2wcR3.dpbs

Prurisol 25% Bioavailability

http://cellceutix.com/cellceutix-signs-agreement-for-clinical-trial-in-europe-on-new-psoriasis-drug/#sthash.pmd1P8rH.dpbs

Ziagen 83% Bioavailability

http://www.rxlist.com/ziagen-drug/clinical-pharmacology.htm



To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News